PL384446A1 - Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method - Google Patents

Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method

Info

Publication number
PL384446A1
PL384446A1 PL384446A PL38444608A PL384446A1 PL 384446 A1 PL384446 A1 PL 384446A1 PL 384446 A PL384446 A PL 384446A PL 38444608 A PL38444608 A PL 38444608A PL 384446 A1 PL384446 A1 PL 384446A1
Authority
PL
Poland
Prior art keywords
methyl
tiazolidynodion
pyridinamino
ethoxy
phenyl
Prior art date
Application number
PL384446A
Other languages
Polish (pl)
Inventor
Michał Chodyński
Wioleta Maruszak
Andrzej Kutner
Magdalena Glice
Anita Pietraszek
Katarzyna Korczak
Hanna Fitak
Marek Kubiszewski
Original Assignee
Adamed Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adamed Spółka Z Ograniczoną Odpowiedzialnością filed Critical Adamed Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL384446A priority Critical patent/PL384446A1/en
Priority to PCT/PL2009/000015 priority patent/WO2009102226A1/en
Publication of PL384446A1 publication Critical patent/PL384446A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
PL384446A 2008-02-12 2008-02-12 Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method PL384446A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL384446A PL384446A1 (en) 2008-02-12 2008-02-12 Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method
PCT/PL2009/000015 WO2009102226A1 (en) 2008-02-12 2009-02-11 Malonic acid salt of 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- 2,4-thiazolidinedione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL384446A PL384446A1 (en) 2008-02-12 2008-02-12 Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method

Publications (1)

Publication Number Publication Date
PL384446A1 true PL384446A1 (en) 2009-08-17

Family

ID=40810587

Family Applications (1)

Application Number Title Priority Date Filing Date
PL384446A PL384446A1 (en) 2008-02-12 2008-02-12 Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method

Country Status (2)

Country Link
PL (1) PL384446A1 (en)
WO (1) WO2009102226A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013068486A1 (en) 2011-11-08 2013-05-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of male infertility
CN109053717B (en) * 2018-08-09 2022-05-31 天津理工大学 Rosiglitazone gentisate and preparation method thereof
CN109053718B (en) * 2018-08-09 2022-06-03 天津理工大学 Rosiglitazone saccharin salt and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306228B1 (en) * 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
WO2003053962A1 (en) * 2001-12-20 2003-07-03 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
CZ298424B6 (en) * 2005-05-24 2007-09-26 Zentiva, A. S. Crystallization process of rosiglitazone and derivatives thereof from mixed solutions

Also Published As

Publication number Publication date
WO2009102226A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
PL384446A1 (en) Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method
IL266563A (en) Heterocyclic compounds useful as pdk1 inhibitors
HK1183875A1 (en) Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl]-4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl]-n- [2-oxo-2- [ ( 2, 2, 2 - trifluoroethyl) amino]ethyl]-1- naphthalenecarboxamide 4-[5-[3--5-()]-45--5-()-3-]-n-[2-- 2-[(222-)]]-1-
IL216349A (en) 4-(1-carboxy-ethylcarbamoyl)-4-(5-[1,2]dithiolan-3-yl-pentanoylamino)-butyric acid derivatives and compositions comprising them
IL207854A0 (en) Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol
ZA201103033B (en) Thioamide compounds, method of making and method of using thereof
IL247136B (en) Compounds for reducing uric acid and uses thereof
ZA201303253B (en) Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-yl-thio)acetic acid and uses thereof
ME02307B (en) Crystalline (r)-(e)-2-(4-(2-(5-(1-(3,5-dichloropyrtdtn-4-yl)ethoxy)-1h-indazol-
HK1162516A1 (en) (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as dgat inhibitors
IL220211A (en) Process for the preparation of 1-(alkyl/phenyl/pyrid-2-yl)-5-pyrazolecarboxylic acid derivatives and intermediates obtained in said process
IL212070A (en) Phenyl and pyridyl derivatives of 7-piperidinoalkyl-3,4-dihydroquinolone
HK1164856A1 (en) Polymorphic forms of 3-(1-3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin- 2-yl]-benzyl-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof 3-(1-3-[5-(1---4-)--2-]--6--16--- 3-)-
EP2381772A4 (en) Process and intermediates for the preparation of n-acylated-4-aryl beta-amino acid derivatives
HK1189591A1 (en) Hydrochloride salt of 5-r3-f3-tivdroxyphenoxy)azetidi-1-v-5-methyl-2 2- diphenylhexanamide 5-[3-(3-)-1-]-5--22-
IL208834A0 (en) Method for the production of halogen-substituted 2-(aminomethylidene)-3- oxobutyric acid esters
IL207431A0 (en) New process for the preparation of cyclohexanecarboxylic acid derivatives
EP2304506A4 (en) Toner having multiple inflection points on storage modulus curve with respect to temperature and method of preparing the same
EP2305673A4 (en) Crystal of thiazolidinedione compound, and process for production thereof
IL213599A0 (en) Improved biocatalysts for manufacturing duloxetine alcohol
PL385697A1 (en) Salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]-2, 4-thiazolidinedione with 1, 5 naphtalene disulfonic acid, and method of its manufacturing
EP2332923A4 (en) 5-[2-(methylthio)ethoxy] and pyrimidine-2-amine manufacturing method
PL385222A1 (en) New N-[2-(alkoxycarbonyl)ethyl]-N-methyl-1-amine-1-deoxy-D-glucitola salts and method of their manufacturing
PL392673A1 (en) Copolymers of photochromic 4-[(E)-[4-[(5-methylisoxazole-3-yl) sulphamoyl]phenyl]azo]phenyl methacrylate and process for the preparation thereof
PL392674A1 (en) Photochromic copolymers of 4-[(E)-[4-[(5-methylisoxazole-3-yl) sulphamoyl]phenyl]azo]phenyl methacrylate and process for the preparation thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)